Novavax, Inc. (Alumni)
1 known investors
Novavax develops protein-based nanoparticle vaccines paired with its Matrix-M adjuvant to produce broad, long-lasting immune responses. It advances a pipeline of vaccine assets targeting areas of unmet medical need and pursues partnerships to commercialize its technology.
Investors · 1
Frequently asked questions
- What does Novavax, Inc. (Alumni) do?
- Novavax develops protein-based nanoparticle vaccines paired with its Matrix-M adjuvant to produce broad, long-lasting immune responses. It advances a pipeline of vaccine assets targeting areas of unmet medical need and pursues partnerships to commercialize its technology.
- Who are Novavax, Inc. (Alumni)'s investors?
- Novavax, Inc. (Alumni)'s investors include Foresite Capital.